Sarah Jane Nader Eliminated From DWTS: Her Dating History, Pete Davidson Rumours And Sexuality Explained

India, Sept. 17 -- Sarah Jane Nader's Dancing With The Stars journey has come to an early end. The Love Thy Nader star and her professional partner Hailey Bills were eliminated during Night 2 of the S... Read More

Home First Finance Company India allots 3,681 equity shares under ESOP

Mumbai, Sept. 17 -- Home First Finance Company India has allotted 3,681 equity shares of Rs 2 each pursuant to exercise of Employee Stock Options under the ESOP schemes of the company. The paid-up sh... Read More

Singapore Clinical Trial: The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA)

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA... Read More

Singapore Clinical Trial: A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible (TE NDMM) (DURGA-6)

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More

Singapore Clinical Trial: A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations'. ... Read More

Singapore Clinical Trial: A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or without Bevacizumab in Comparison to Active Observation with or without Bevacizumab as Maintenance Treatment in Participants with Newly Diagnosed FIGO Stage III/IV Non-Homologous Recombination Deficient Ovarian Cancer

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More

Singapore Clinical Trial: An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-08634404 Monotherapy or in Combination in Adult Participants with Early-Stage Resectable or Locally Advanced Unresectable Non-Small Cell Lung Cancer

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-0863440... Read More

Singapore Clinical Trial: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of MLC901 (NeuroAiD™II) in subjects with mild to moderate Alzheimer’s Disease (AD).

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the e... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muval... Read More

Singapore Clinical Trial: GC-LTFU-001: Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'GC-LTFU-001: Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells'. The f... Read More

• ««
• «
• 3351
• 3352
• 3353
• 3354
• 3355
• 3356
• 3357
• 3358
• 3359
• 3360
• »
• »»